American College of Cardiology
ACC 2012: Stent news from Medtronic, Boston Scientific, OrbusNeich
ACC 2012: Boston Scientific swats stent deformation concerns
Boston Scientific (NYSE:BSX) sought to dispel concerns that its thinner next-generation stents may be more prone to crumpling than some other models with the release of results from 2 randomized clinical trials which found no instances of deformation with the med-tech titan’s newest stents.
MassDevice.com +3 | The top 3 med-tech stories for March 27, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
ACC 2012: Bypass surgery beats PCI at 4 years | MassDevice.com On Call
MASSDEVICE ON CALL — Coronary artery bypass surgery beat out percutaneous stenting for mortality rates after 4 years in a large observational study of nearly 200,000 patients aged 65 and older, according to a new study unveiled at this week’s American College of Cardiology conference in Chicago.
The analysis was adjusted to control for factors such as age, sex, diabetes, renal function and lung disease, and researchers concluded that CABG patients lived longer, "even among patients whose propensity scores were most consistent with selection for PCI."
MassDevice.com +3 | The top 3 med-tech stories for March 26, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
ACC 2012: St. Jude’s recalled Riata plagued with problems, but docs upbeat on Durata
St. Jude Medical’s (NYSE:STJ) troubled Riata defibrillator lead was again the focus of attention today as a new study released at the American College of Cardiology conference in Chicago noted multiple issues with the wires that could lead to melted components and unnecessary shocks.
ACC 2012: Medtronic and Edwards rise on lower stroke rates in new TAVI data
ACC 2012: TAVI stands up to surgery at 2 years, but valve leak risk increases
IBM’s Watson supercomputer tackles cancer | MassDevice.com On Call
MASSDEVICE ON CALL — IBM’s Jeopardy-winning Watson supercomputer is taking a swing at oncology research in efforts to help hospitals more quickly diagnose and treat cancer.
Watson can cull through 200 million pages of information in less than 3 seconds, according to IBM, and the machine is getting an education in oncology at Manhattan’s Memorial Sloan-Kettering Cancer Center.
Study warns of $840M in potentially unneeded PCIs, docs debate appropriate use
The debate over the appropriate use of percutaneous coronary interventions began brewing again as cardiologists argue over the guidelines for ordering the procedures and a study hints at substantial overuse.
A recent study of more than 1 million PCIs performed at nearly 700 hospitals found that around 4% were conducted in patients without clear indication.